ABSTRACT: The recombinant Kv7.2 calmodulin (CaM) binding site (Q2AB CaMBD) shows a high tendency to aggregate, thus complicating biochemical and structural studies. To facilitate these studies we have conceived bis-PEG-peptide CaMBD-mimetics linking helices A and B in single, easy to handle molecules. Short PEG chains were selected as spacers between the two peptide molecules, and a Cu(I)-catalyzed cycloaddition (CuAAC) protocol was used to assembly the final bis-PEG-peptide conjugate, through the convenient functionalization of PEG arms with azide and alkyne groups. The resulting conjugates, with a certain helical character in TFE solutions (CD), showed nanomolar affinity in a fluorescence CaM binding in vitro assay, higher than just the sum of the precursor PEG-peptides affinities, thus validating our design. The approach to these first described examples of Kv7.2 CaMBD-mimetics could pave the way to chimeric conjugates merging helices A and B from different Kv7 subunits.
INTRODUCTION
Kv7.2 and Kv7.3 subunits, encoded by the KCNQ2 and KCNQ3 genes, are the main components of the M-current, a voltage-dependent, non-inactivating K + current that plays a critical role in controlling the activity of both peripheral and central neurons. 1 Like all Kv channels, the α subunits of the five members of the KCNQ family share a common core structure of six transmembrane segments with a voltage sensing domain (S1-S4) and a pore domain (S5 and S6; see Figure 1 ). 2 The large intracellular C-terminal tail contains four helical regions (A-D) crucial to channel assembly, gating and regulation, including the intercommunication with different regulatory factors. Discontinuous segments A and B¸ with high probability of adopting α-helix conformations, constitute the binding site for calmodulin (CaM), 3 a ubiquitous calcium sensor which mediates traffic to the plasma membrane and Ca
2+
-dependent inhibition of Kv7 channels. [4] [5] [6] Some spontaneous mutations located in helix A or B interfering with CaM binding, are linked to familial Benign Familial Neonatal
Convulsions (BFNC), 1 a dominantly inherited idiopathic human epilepsy. The "Benign" tag is misleading, because these mutations are often associated with poor outcomes. Although the knowledge about the Kv7-CaM interrelationship has advanced in recent years, [9] [10] [11] fundamental aspects of the interaction are not known. Thus, a recent X-ray structure of the complex between CaM and the Kv7.4 helix B peptide has trapped Ca 2+ /CaM wrapping around the helix B in an antiparallel 1-14 binding-mode. 12 However, this study only provides partial information about CaM binding to the Kv7 channels, since these channels have two CaM binding sites that are essential for the final binding mode of the complex. 3, 13 For instance, it is expected that helices A and B interact with each other while binding to CaM, 14 as described for other channels. 15 In fact, we have found that CaM binds to either recombinant or synthetic helix A or B peptides, and the two sites cooperate to increase the affinity for this Ca 2+ sensor. 14 However, the long loop of 141 residues between helices A and B does not seem to be directly involved in the interaction with CaM, 3 although this linker regulates both surface expression and protein production. 16 The remarkable tendency of the recombinantly produced Kv7.2 CaM binding site (Q2AB CaMBD) to aggregate has precluded detailed biochemical and structural studies, and the chemical synthesis of the Q2AB CaMBD (> 100 amino acids) is impractical. An alternative to overcome these technical obstacles is to synthetize Q2AB CaMBD-mimetics that retain the fundamental properties regarding CaM-binding by joining A and B fragments in a unique molecule.
Herein, we report the design and synthesis of two poliethyleneglycol PEG-peptide conjugates combining the amino acid sequence of helices A and B of Kv7.2. A 1,4-disubstituted 1,2,3-triazolyl scaffold was selected to join the two helical peptides in a single molecule (Figure 2 ). This heterocycle is easily accessible from alkyne and azide-substituted precursors using click chemistry, a well-recognized, powerful tool in bioconjugation. 17 As a first requirement for these conjugates to be further used as biological probes, we also report that the binding properties recapitulate those of the recombinant Q2AB CaMBD, and are not the result of the sum of the values of its precursors. 15 and consequently the linkers to connect both molecules were incorporated at C-and N-terminal positions, respectively ( Figure 2 ). For this purpose, C-terminal Asn and N-terminal Lys functionalized side-chains were considered appropriate points for anchoring the spacer.
RESULTS AND DISCUSSION
Taking into account that solubility could be an issue for peptides longer than 6 residues, the linker could be selected to improve this property in the bis-A-B peptide conjugates in aqueous media. To this end, we envisaged the use of short poliethyleneglycol (PEG) units, a well-established strategy for peptide modification that improves not only aqueous solubility, but also increases enzymatic stability and could reduce antigenicity and immunogenicity. [19] [20] [21] Moreover, site-specific PEGylation of peptides was described to contribute to the stabilization of particular peptide secondary structures. [22] [23] [24] To connect the PEG-peptides we opted for a 1,4-disubstituted 1,2,3-triazolyl ring, which could be built by Cu(I)-catalyzed azide-alkyne cycloaddition, one of the most widely used Click chemistry reactions. 17 This reaction is highly chemoselective, and can be performed in aqueous solution under mild conditions, being compatible with deprotected peptide side-chain functional groups. [25] [26] [27] In fact, this 1,3-dipolar cycloaddition was already successfully applied to combine peptides and PEG-containing molecules, as in the synthesis of biodegradable peptide-based hydrogels and in the fluorescent labeling of nisin lantibiotics, to cite two representative examples. 28, 29 To provide the conjugate molecule with certain flexibility upon CaM binding, a commercial 1-aminotriethyleneglycol derivative, bearing an azido group at the end, was chosen to get the functionalize Asn 350 residue of helix A ( Figure 3 ). For helix B-derived peptides, a pent-4-ynoyl-substituted 1-aminodiethyleneglycol-7-carboxyl moiety was attached in two steps to the Lys 508 amino side-chain group. This led to final linkers of similar length on both peptides that, upon transformation into the triazole-PEG-peptide conjugates, could force the motion of the two peptide arms in an antiparallel disposition. As the triazole ring can constitute a bend point, we preferred the indicated side-chain to side-chain location over placing it at the very N-or C-terminal positions, which could result in conjugates unable to bring close together the two peptides or that could align them in a wrong way. Thus, after elongation to resin bound peptide 1, the Fmoc group was removed, the N-terminal NH 2 was acetylated, followed by the Pd-catalyzed deallylation of the C-terminal Asp residue side-chain. On resin coupling with a DMF solution of 11-azido-3,6,9-trioxaundecen-1-amine in the presence of HCTU afforded the corresponding Asn derivative, which upon acidic treatment led to cleavage from the resin, and concomitant side chain deprotection, to the expected Peptide-PEG-azide conjugate 2. 
Scheme 2. SPPS Synthesis of alkyne-PEG-Helix B
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Crude peptide-conjugates were precipitated from diethyl ether, centrifuged and lyophilized, and finally purified by reverse phase MPLC using SPE cartridges or by semipreparative RP-HPLC-MS to obtain compounds 2, 5 and 6 in high purity (>98%, HPLC-MS data), which were characterize by ESI + MS and HRMS.
With Helix A
329-350
-PEG-azide conjugate 2 and alkyne-PEG-Helix B 509-527 derivatives 5 and 6 in hand,
we initiated the study of the Click reaction to combine them (Scheme 3). The conditions for the 1,3-dipolar cycloaddition were initially studied for the reaction between compounds 2 and 6, this latter lacking the Cys and Met residues of the native fragment, and therefore less prone to oxidation. We found Cys, Yaa = Met; 8: Xaa = Arg, Yaa = Leu). Compounds 7 and 8 were obtained in high purity (>97%, HPLC data, Figure 4 ) after purification of reaction crudes by reverse-phase semipreparative HPLC.
Characterization of these peptide conjugates was performed by HPLC-MS and HRMS (EI + ). 
CD Studies.
To evaluate the ability of mono-and bis-peptide conjugates to adopt helical structures, circular dichroism (CD) were performed ( Figure 5 and S2). Most peptides showed no defined structure (random coil) in aqueous solution, and only compound 7 has a certain stabilization of the helix conformation ( Table 1 ). All of them become helical upon the addition of TFE (30%), as indicated by the characteristic double minimum at 208 and 222 nm. The fact that these peptides turn into helix conformation in the presence of the structure-inducing cosolvent could be symptomatic of a tendency to be helical in a suitable environment (i.e., in the presence of CaM). As shown in Table 1 , helix B-containing conjugates 5 and 6 are highly helical (<90% helicity in TFE), while the helix character of the PEG-helix A peptide 2 is smaller (24%). Bispeptide conjugates showed an intermediate situation, with mimetic 7 being clearly more helical (35%) than analogue 8 (11%). While the C515R and M517L changes do not significantly affect helicity of PEG-peptide 6 compared to native 5, these changes disturb in a greater extent the structuration of bis-PEG-peptide 8 related to 7. These results suggest an interrelation between the two helical segments in the bisconjugates that is disrupted by the indicated changes. Tables 2 and S1; K D , Table S2 ).
As shown in Figure 6 , bis-PEG-peptide conjugate 7 is able to augment the fluorescent emission of the reporter CaM in a saturable dose-dependent manner, indicating a direct interaction of the conjugate with
CaM. The position of the reporter fluorophore had little impact of the binding affinity (Table S1) 14 and follows the same trend in the presence (lower affinity) and the absence of Ca 2+ (higher affinity). Thus, compound 7 appears to be a reasonable mimetic for the Kv7.2 CaM binding site. Because the observed binding of bis-conjugate 7 could be explained trough the interaction of CaM with a single helix (A or B) or with both helices at a time, precursors PEG-peptides 2 (helix A) and 5 (helix B) were also studied ( Figure 7 , and S5). In total agreement with previous results regarding recombinant or synthetic peptides derived from helix A or B, 14 compound 2 (helix A) showed greater increase in fluorescence than helix B-derived compound 5, but this latter displayed higher affinity (Tables 2 and S1 ). While the amplification of D-CaM fluorescent emission by PEG-peptide conjugate 2 was slightly lower than that of peptide pA (using the same assay), the apparent affinities were almost identical irrespective of the presence of Ca 2+ or not. This indicates that the polyethyleneglycol has a negligible impact on binding to CaM. Compared to peptide pB, PEGconjugate 5 showed decreased apparent affinities, which could be due to either a negative influence of the PEG chain or to the differences in the sequence (lack of N-terminal GL residues, and/or detrimental effects of the C-terminal KRKF sequence). Both the maximal increase in fluorescence and the apparent affinity were greater for a 1:1 mixture of compounds 2 and 5 than for each peptide conjugate alone, in concordance with previous results for an equimolar mixture pA and pB. 14 While interacting with CaM, the 2+5 mixture showed a lower increase of fluorescence and apparent affinities than the covalently connected bis-conjugate 7, suggesting a favorable role for the PEG linker in facilitating binding. 515 and Met 517 residues of helix B in 7 by Arg and Leu, respectively, led to bisconjugate 8, which decreases to approximately half the fluorescence and apparent affinity (i.e doubling the EC 50 ) compared to 7 (Table 2, Figure S4 ). In the crystal structure of the Ca 2+ -CaM:Kv7.4 B-helix complex, this leucine was defined as a key interacting residue, occupying the main hydrophobic anchoring pocket of the Ca 2+ -N-lobe 12 . As the Met by Leu change is conservative, it is expected that this Leu could contribute to the conjugate 8-CaM interaction in the same way than in above complex. However, the more drastic replacement of Cys by Arg is suggestive of an important role of Cys 515 in the binding of Kv7.2 to CaM. The decreased helical stability of compound 8 in solution could also be related, at least in part, to the diminished affinity, requiring of higher energy to accommodate within the CaMpeptide complex. The error bars are smaller than the symbols. The parameters used to fit a Hill equation to the data, using 12.5 nM fluorescent CaM, can be found in Table 2 and S1. The Kd values can be found in Table S2 . CaM, can be found in Table 2 and S1. The Kd values can be found in Table S2 . 
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CONCLUSIONS
We have designed and synthesized a bis-PEG-peptide conjugate, HelixA (0.5 ml, 3.6 mmol) in anhydrous DCM (1 ml/100 mg of resin). The reaction mixture was stirred for 45 min. This procedure was repeated once more time. The resin was washed with DCM/DMF/Et 2 NCS 2 Na (0.02M)/DMF/DCM (4 x 0.5 min).
Cleavage step. Cleavage of peptides from the resin, and concomitant deprotection of side-chains, was performed using TFA/EDT/H 2 O/TIPS (94:2.5:2.5:1) (1 ml/100 mg of resin) at room temperature for 3 h. The resin was filtered off and crude products were precipitated with cold Et 2 O. The resulting solid was centrifuged and washed twice with ether, and then lyophilized. Accurate-Mass Q-TOF LC/MS equipment).
Ac-FEKRRNPAAGLIQSAWRFYATN(2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethyl)-NH 2 (2).
Resin-bound peptide (500 mg, 0.17 mmol) 1, incorporating Asp(OAll) at C-terminal, was synthesized using cleaved following the general procedure described above. Proteins. Recombinant rat brain calmodulin (CaM) was produced in E.coli strain BL21-DE3 and purified as described. 9 Dispersion of the samples was evaluated by dynamic light scattering (DLS) using a Zetasizer Nano instrument (Malvern Instruments Ltd.) in order to exclude the presence of aggregates.
Ac-K[2-(2-(Pent-4-ynamido)ethoxy)ethoxy)acetyl]VSIRAVCVMRFLVSKRKF-NH 2 (5).
Fluorometry. Fluorescent dansylated CaM (D-CaM, 5-(dimethylamino)naphtalene-1-sulfonylcalmodulin) was prepared using recombinant CaM and dansyl chloride as described. 33 CaM with a T to C mutation at threonine 34 or 110 and labeled with 5- ((((2-iodoacetyl) 
